UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2020 2020-05-04 0.00 0.00
Q4 2019 2020-03-12 -0.14 -0.14
Q3 2019 2019-11-04 -0.17 -0.17
Q2 2019 2019-08-01 -0.19 -0.19
Q1 2019 2019-05-02 -0.19 -0.19
Q4 2018 2019-03-13 0.01 0.01
Q3 2018 2018-11-01 -0.26 -0.26
Q2 2018 2018-08-02 -0.20 -0.20
Q1 2018 2018-05-03 -0.08 -0.08
Q4 2017 2018-03-07 -0.33 -0.33

Ratings

2016-02-10 Downgrade WallachBeth Capital Hold to Sell
2016-02-10 Downgrade Piper Jaffray Overweight to Neutral $4.00 to $0.75
2016-02-10 Downgrade Ladenburg Thalmann Buy to Neutral
2016-02-10 Downgrade Piper Jaffray Cos. Overweight to Neutral $4.00 to $0.75
2016-02-08 Lower Price Target Piper Jaffray Overweight $8.00 to $4.00
2016-02-08 Lower Price Target S&P Equity Research $0.48 to $0.39
2016-01-05 Reiterated Rating Piper Jaffray Overweight $8.00
2015-12-10 Reiterated Rating Piper Jaffray Buy
2015-11-09 Downgrade WallachBeth Capital Buy to Hold $4.50 to $1.60
2015-09-23 Reiterated Rating Piper Jaffray Buy $8.00
2015-08-14 Reiterated Rating Roth Capital Buy $4.50
2015-06-01 Set Price Target Roth Capital Buy $4.50
2015-06-01 Reiterated Rating Janney Montgomery Scott Buy to Fair Value $3.50 to $1.94
2015-05-10 Reiterated Rating HC Wainwright Buy $6.00 to $4.00
2015-03-23 Set Price Target Roth Capital Buy $4.50
2015-03-09 Set Price Target Piper Jaffray $6.00 to $8.00
2014-09-08 Initiated Coverage Piper Jaffray Overweight $6.00
2014-08-05 Upgrade WallachBeth Hold to Buy $4.50
2014-08-05 Upgrade WallachBeth Capital Hold to Buy $4.50
2014-05-22 Initiated Coverage Ladenburg Thalmann Buy $6.00
2014-03-19 Initiated WallachBeth Hold $4.50
2014-03-19 Initiated Coverage WallachBeth Capital Hold $4.50
2013-11-04 Initiated Coverage HC Wainwright Buy $4.00
2013-10-29 Initiated Coverage Janney Montgomery Scott Buy
2013-10-07 Reiterated Rating Wells Fargo & Co. Positive
2013-10-07 Reiterated Rating Wells Fargo Positive
2016-02-10 Downgrade WallachBeth Capital Hold to Sell
2016-02-10 Downgrade Piper Jaffray Overweight to Neutral $4.00 to $0.75
2016-02-10 Downgrade Ladenburg Thalmann Buy to Neutral
2016-02-10 Downgrade Piper Jaffray Cos. Overweight to Neutral $4.00 to $0.75
2016-02-08 Lower Price Target Piper Jaffray Overweight $8.00 to $4.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
ORBIMED ADVISORS LLC 3.33%  (5000000) AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN /
BIANCO JAMES A President and CEO 1.19%  (1780133) CTIC /
BVF PARTNERS L P/IL 0.86%  (1295582) ARQL / ARRY / CAPS / CCXI / CNCE / CTIC / INFI / LGND / NBIX / ONTY / PTN / RGDO / RGEN / RIGL / TRGT / XENE /
SINGER JACK W EVP, Global Medical Affairs 0.66%  (994057) CTIC /
BIANCO LOUIS A EVP, Finance & Administration 0.42%  (622933) CTIC /
BAUER JOHN H 0.40%  (599011) CTIC /
Plunkett Matthew EVP, Corporate Development 0.35%  (526210) CTIC /
GREGORIAN VARTAN 0.31%  (468937) CTIC /
BENNER STEVEN E EVP, Chief Medical Officer 0.24%  (363371) CTIC /
MUNDINGER MARY ONEIL 0.24%  (360019) CTIC /
SEELEY BRUCE J. EVP, Chief Commercial Officer 0.21%  (310000) CTIC / NSTG /
Tuckson Reed Vaughn 0.06%  (92424) CTIC / LPNT /
Telling Fred 0.05%  (78874) CTIC / OGEN /
LOVE RICHARD L 0.05%  (73718) CTIC / PRXL /
NUDELMAN PHILLIP M PHD 0.05%  (73129) CTIC /
Ignagni Karen 0.04%  (66192) CTIC /
PERRY MATTHEW D See Explanation of Responses 0.03%  (43139) CTIC / XOMA /
Metzger Michael A 0.01%  (20121) CTIC / RGDO / RGDX /

Comments